The Impact of Surfactants in Tailoring Nanostructured Lipid Carriers for Inhaled Levofloxacin. (PubMed, ACS Omega) - Aug 29, 2026 - "Concerning device compatibility, P407-stabilized NLCs retained their size and PDI within the same range after nebulization through a vibrating mesh, which is favorable for future pulmonary delivery. In summary, these findings highlight the importance of surfactant type selection, indicating the preliminary feasibility of the P407-based formulation and providing a foundation for future investigations on the pulmonary delivery of LV."
Journal • Cystic Fibrosis • Genetic Disorders • Immunology • Infectious Disease • Influenza • Pneumonia • Pulmonary Disease • Respiratory Diseases
|
|
Catarina Raposo; Gabriel da Silva Cordeiro; João Paulo Guarnieri; Karina Cogo-Müller; Laura Oliveira-Nascimento; Marcelo Lancellotti; Marcelo van Vliet Lima; Samira Elisa Alves Geraldo; Viviane Lucia Beraldo de Araujo
|